New Zealand markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5900-0.0800 (-4.79%)
At close: 04:00PM EDT
1.6300 +0.04 (+2.52%)
After hours: 07:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
75,475
75,475
78,447
227,547
148,364
Cost of revenue
26,967
26,967
14,217
2,392
-
Gross profit
48,508
48,508
64,230
225,155
-
Operating expenses
Research development
118,927
118,927
105,975
146,936
175,611
Selling general and administrative
109,082
109,082
184,985
199,615
65,854
Total operating expenses
228,009
228,009
290,960
346,551
241,465
Operating income or loss
-179,501
-179,501
-226,730
-121,396
-93,101
Interest expense
56,810
56,810
46,353
22,670
8,120
Total other income/expenses net
2,652
2,652
3,975
515
4,056
Income before tax
-233,659
-233,659
-269,108
-143,551
-97,165
Income from continuing operations
-233,659
-233,659
-269,108
-143,551
-97,165
Net income
-233,659
-233,659
-269,108
-143,551
-97,165
Net income available to common shareholders
-233,659
-233,659
-269,108
-143,551
-97,165
Basic EPS
-
-3.52
-9.31
-5.23
-3.59
Diluted EPS
-
-3.52
-9.31
-5.23
-3.59
Basic average shares
-
66,407
28,903
27,474
27,090
Diluted average shares
-
66,407
28,903
27,474
27,090
EBITDA
-
-176,349
-222,143
-120,334
-88,726